Circulation Vol 81, No 3, March 1990 4) Safety of high-dose dipyridamole infusion. We have previously reported preliminary data on the safety of high-dose DET in 952 studies.5 More recently, data on the updated experience derived from a large-scale multicenter trial involving 12 echocardiography laboratories in Italy have become available.'0 Until now (and in full accord with the preliminary experience reported from our group5), 2,401 high-dose DET studies have been performed according to the protocol proposed in 1986.4 This protocol requires that 1) two-dimensional echocardiographic monitoring be continuously performed throughout the test and that aminophylline be immediately given whenever obvious dyssynergy is detected and that 2) the high dose (0.28 mg/kg during a 2-minute period) be given only when the test is still negative for echocardiographic criteria at the fourth minute after the low standard dose (0.56 mg/kg during a 4-minute period). It was found that no major side effects occurred (i.e., death, myocardial infarction, or severe arrhythmias) and that more severe forms of myocardial ischemia (aminophylline-resistant ischemia and ST segment elevation in the absence of resting Q wave) were always elicited by the lower "standard" dose (0.56 mg/kg during 4 minutes). Of note, 305 studies were performed early (< 15 days) after an acute myocardial infarction.10 When continuous echocardiographic monitoring is combined with graded administration of dipyridamole, the higher dose did not imply a greater risk.'0 5) Study population. As clearly shown in Table 7 of our study,1 the prognostic value of DET is apparent also in the subset of patients without myocardial infarction, insofar as hard end points are concerned. Using the Cox model, we found that in this subset the most significant predictor of subsequent events (death and myocardial infarction) was a positive DET (A)=7.3, p<0.01).
Finally, we thank Dr. Gerson for acknowledging that we have made a series of new and potentially important observations about DET. We cannot share his concerns on the supposed "major limitations" of the study but certainly agree that we need much larger study populations and multicenter experience on various patient subsets, as well as more follow-up information, to have a clearer idea about the safety, usefulness, and prognostic accuracy of DET. Our view is that, at the moment, high-dose DET is midway on the bridge that links a "promising" test to an extensively applied diagnostic procedure. Substantial, further information is required for community hospital use, but no real stepup in information will be provided until larger scale application is made. Please do not forget DET is only 5 Paradis and colleagues' recently reported on a pressure gradient between the right atrium and the jugular vein bulb during chest compression in 22 adult patients who suffered cardiac arrest. A maximum right atrium to jugular vein bulb pressure gradient of 26 mm Hg during compression "systole" and a minimum gradient of -2 mm Hg during compression "diastole" were demonstrated in these patients during closed-chest cardiac resuscitation. These findings are consistent with early studies by Niemann et a12 in dogs and by Fisher et al3 in humans that demonstrated competent venous valves at the superior thoracic inlet.
We applaud the efforts of the investigators and believe that additional confirmation of venous valve function in humans is of significant interest. Such valve function would impede backflow of blood from the intrathoracic venous reservoir into the jugular vein system during chest compression. However, we differ with the conclusion reached by Paradis and colleagues' that this is evidence of a thoracic pump mechanism of blood flow. According to the thoracic pump theory, the forward blood flow that is generated during precordial compression results from a global increase in intrathoracic pressures. Furthermore, the proponents of this theory believe that the heart represents a passive conduit.2.4.5 This contrasts with traditional cardiac pump theory that blood flow is generated by selective compression of the heart. 6 Gudipati et a17 from our group reported in preliminary form on venous valve function at the thoracic inlet during closed-chest precordial compression in pigs. However, such valve function was demonstrated when the chest was compressed after it was vented to the atmosphere following laparotomy and excision of both diaphragmatic domes. Moreover, in the open-chest preparation, direct (manual) compression of the heart produced the very same valve function both with and without the pericardium intact (Figure) .
Accordingly, we would interpret the data reported by Paradis et all as indicative of valve function but without the implications that it is specifically due to increases in intrathoracic pressure or that it indicates a thoracic pump mechanism.
Raul J. Gazmuri, MD Reply Gazmuri et al are correct in pointing out that demonstration of functioning venous valves during cardiopulmonary resuscitation is not evidence of a thoracic pump mechanism. As we state in our article,' "this venous valve is consistent with the thoracic pump model." Its absence would have argued against a thoracic pump as the mechanism of cerebral perfusion in our patients, but its presence does not prove the pump's existence. For a thoracic pump to function, a similar gradient between the aorta and carotid arteries would have to be excluded, a study we are currently performing.
Our conclusion that a thoracic pump mechanism was responsible for any cerebral perfusion was based on the simultaneous presence of a significant aortic to jugular venous bulb gradient and a minimal or absent aortic to right atrial gradient during the compression phase in most of our patients. This is only suggestive, however, because cerebral perfusion was not itself demonstrated. Animal studies purporting to demonstrate cardiac compression during cardiopulmonary resuscitation have found an aortic to right atrial gradient during compression of at least 20 mm Hg.2 This gradient was much smaller in our patients, which, in our view, indicates a lack of cardiac compression. Despite this, it appears that the jugular valves can produce a gradient across the brain even in the absence of cardiac compression. This is consistent with our hypothesis that the thoracic and cardiac pump mechanisms are not mutually exclusive. We are currently attempting to determine which mechanism is important in the return of spontaneous circulation.
